{"id":2043,"date":"2018-09-13T10:16:11","date_gmt":"2018-09-13T14:16:11","guid":{"rendered":"https:\/\/3sixtypharma.com\/?p=2043"},"modified":"2018-09-13T11:47:45","modified_gmt":"2018-09-13T15:47:45","slug":"risk-management-in-device-trials","status":"publish","type":"post","link":"https:\/\/3sixtypharma.com\/2018\/09\/13\/risk-management-in-device-trials\/","title":{"rendered":"Risk Management in Device Trials – What You Need to Know"},"content":{"rendered":"
Risk management can be an obscure concept in some organizations, largely because it seems complicated and a challenge to wrap one’s arms around, especially in the medical devices space.<\/p>\n
However, if you have a roadmap it can be fairly straight-forward.<\/p>\n
The latest article by 3Sixty Pharma Solutions’ Subject-Matter Expert, Claudia Campbell<\/strong>, provides just that.<\/p>\n Check out Managing Risk For Medical Device Clinical Trials<\/a> and begin to effectively navigate the murkiness of “risk management”!<\/em><\/strong><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" Risk management can be an obscure concept in some organizations, largely because it seems complicated and a challenge to wrap one’s arms around, especially in the medical devices space. However, if you have a roadmap it can be fairly straight-forward. The latest article by 3Sixty Pharma Solutions’ Subject-Matter Expert, Claudia Campbell, provides just that. Check[…]<\/a><\/p>\n","protected":false},"author":2,"featured_media":2046,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[8],"tags":[],"class_list":["post-2043","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/3sixtypharma.com\/wp-content\/uploads\/2018\/09\/3Sixty-Pharma-Solutions_Risk-Management-in-Medical-Device-Clinical-Trials.png?fit=375%2C250&ssl=1","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7wLmz-wX","jetpack_likes_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts\/2043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/comments?post=2043"}],"version-history":[{"count":0,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts\/2043\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/media\/2046"}],"wp:attachment":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/media?parent=2043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/categories?post=2043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/tags?post=2043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}